HYPERION DEFI, INC. Other Research and Development Expense
HYPERION DEFI, INC. (HYPD) reported Other Research and Development Expense of $2.22 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2026-08-13
- HYPERION DEFI, INC. other research and development expense for the quarter ending 2026-06-30 was $2.22K, a 84.75% decline year-over-year.
- HYPERION DEFI, INC. other research and development expense for the quarter ending 2026-03-31 was $3.88K, a 80.35% decline year-over-year.
- HYPERION DEFI, INC. other research and development expense for the quarter ending 2025-06-30 was $14.56K, a 78.98% decline year-over-year.
- HYPERION DEFI, INC. other research and development expense for the quarter ending 2025-03-31 was $19.74K.
- HYPERION DEFI, INC. other research and development expense for fiscal 2025 was $42.16K, a 89.70% decline from fiscal 2024.
- HYPERION DEFI, INC. other research and development expense for fiscal 2024 was $409.46K.
| Period end | Other Research and Development Expense 3 month | Other Research and Development Expense 6 month | Other Research and Development Expense 12 month |
|---|---|---|---|
| 2026-06-30 | $2.22K 10-Q · filed 2026-08-13 | $6.10K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.88K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $42.16K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $14.56K 10-Q · filed 2026-08-13 | $34.30K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $19.74K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $409.46K 10-K · filed 2026-03-30 | ||
| 2024-06-30 | $69.25K 10-Q · filed 2025-08-13 | $114.41K 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |